MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 84 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $761,128 | +19.5% | 94,550 | +61.2% | 0.00% | 0.0% |
| Q2 2023 | $637,048 | +15.6% | 58,660 | -48.4% | 0.00% | 0.0% |
| Q2 2022 | $551,000 | -48.2% | 113,779 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,064,000 | -8.4% | 113,779 | +16.3% | 0.00% | 0.0% |
| Q4 2021 | $1,162,000 | -0.2% | 97,849 | -4.3% | 0.00% | 0.0% |
| Q3 2021 | $1,164,000 | -31.8% | 102,269 | +7.6% | 0.00% | -50.0% |
| Q2 2021 | $1,706,000 | +20.4% | 95,079 | +3.8% | 0.00% | +100.0% |
| Q1 2021 | $1,417,000 | +36.2% | 91,559 | +7.4% | 0.00% | 0.0% |
| Q4 2020 | $1,040,000 | -18.4% | 85,229 | -14.0% | 0.00% | -50.0% |
| Q3 2020 | $1,274,000 | – | 99,109 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 3,629,622 | $41,305,000 | 7.74% |
| VR Adviser, LLC | 2,641,809 | $30,064,000 | 3.86% |
| Bleichroeder LP | 1,062,500 | $12,091,000 | 1.96% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $16,285,000 | 1.01% |
| Boxer Capital, LLC | 2,400,000 | $27,312,000 | 0.95% |
| 683 Capital Management, LLC | 1,929,929 | $21,963,000 | 0.86% |
| Avoro Capital Advisors LLC | 3,235,000 | $36,814,000 | 0.58% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,197,426 | $25,007,000 | 0.42% |
| Granite Point Capital Management, L.P. | 419,324 | $4,772,000 | 0.36% |
| KNOTT DAVID M | 81,166 | $924,000 | 0.34% |